U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07663786) titled 'Evaluation of Esophagogastric Cancer Treatment With Nivolumab in Daily Clinical Practice' on June 17.
Brief Summary: This study uses existing cancer registry and health record data to understand how nivolumab is used in routine care in the Netherlands for adults with advanced cancers of the esophagus, gastroesophageal junction, or stomach.
Study Start Date: Oct. 09, 2025
Study Type: OBSERVATIONAL
Condition:
Esophageal Adenocarcinoma
Gastro-esophageal Junction Adenocarcinoma
Gastric Adenocarcinoma
Intervention:
DRUG: Nivolumab
As per product label
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Bristol-Myers Squibb
Publi...